Literature DB >> 1924756

Severity of organ injury as a predictor of acute mortality for disparate patterns of absorbed dose distribution.

V P Bond1, A L Carsten, J Bullis, S P Roth.   

Abstract

Nonuniform distribution of absorbed dose is frequently encountered in the irradiated mammal; the degree of nonuniform distribution is generally more severe as the size of the animal increases and the energy or penetrating power of the radiation decreases. However, acute mortality under these conditions, e.g., from the hematopoietic syndrome, appears not to be consistently predictable from the dose at any given location or locations within the animal. It is thus reasonable to seek a biological quantity that may be adequate for this purpose. Accordingly, it was postulated that, in animals dying from the bone marrow syndrome, survival is determined by the total number of viable stem cells remaining in the entire body, independent of their distribution. To test this hypothesis, the LD50/30 value for mice exposed to nonuniform irradiation of varying degrees of severity was obtained, as was that for mice receiving uniform total-body irradiation. The distribution of bone marrow in transverse segments of tissue along the spinal axis was determined, as was the dose to each of the segments. The data were analyzed by multiplying, for each segment, the fraction of stem cells in the fraction of cells surviving, as determined from the dose and a survival curve for stem cells determined separately. The sum of these products yielded the surviving number of stem cells in the total mouse, for both the uniformly and nonuniformly exposed animals. The surviving fraction was found to differ by no more than 20%; this was taken to be reasonable evidence that, based on the number of surviving stem cells, it is possible to predict the mortality rate for both uniform and markedly nonuniform irradiation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1924756

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  5 in total

1.  Citrulline as a Biomarker in the Non-human Primate Total- and Partial-body Irradiation Models: Correlation of Circulating Citrulline to Acute and Prolonged Gastrointestinal Injury.

Authors:  Jace W Jones; Alexander Bennett; Claire L Carter; Gregory Tudor; Kim G Hankey; Ann M Farese; Catherine Booth; Thomas J MacVittie; Maureen A Kane
Journal:  Health Phys       Date:  2015-11       Impact factor: 1.316

2.  The Natural History of Acute Radiation-induced H-ARS and Concomitant Multi-organ Injury in the Non-human Primate: The MCART Experience.

Authors:  Ann M Farese; Catherine Booth; Greg L Tudor; Wanchang Cui; Eric P Cohen; George A Parker; Kim G Hankey; Thomas J MacVittie
Journal:  Health Phys       Date:  2021-10-01       Impact factor: 2.922

3.  The prolonged gastrointestinal syndrome in rhesus macaques: the relationship between gastrointestinal, hematopoietic, and delayed multi-organ sequelae following acute, potentially lethal, partial-body irradiation.

Authors:  Thomas J MacVittie; Alexander Bennett; Catherine Booth; Michael Garofalo; Gregory Tudor; Amanda Ward; Terez Shea-Donohue; Daniel Gelfond; Emylee McFarland; William Jackson; Wei Lu; Ann M Farese
Journal:  Health Phys       Date:  2012-10       Impact factor: 1.316

4.  The Effect of Radiation Dose and Variation in Neupogen® Initiation Schedule on the Mitigation of Myelosuppression during the Concomitant GI-ARS and H-ARS in a Nonhuman Primate Model of High-dose Exposure with Marrow Sparing.

Authors:  Thomas J MacVittie; Alexander W Bennett; Ann M Farese; Cheryl Taylor-Howell; Cassandra P Smith; Allison M Gibbs; Karl Prado; William Jackson
Journal:  Health Phys       Date:  2015-11       Impact factor: 2.922

5.  A Systematic Review of the Hematopoietic Acute Radiation Syndrome (H-ARS) in Canines and Non-human Primates: Acute Mixed Neutron/Gamma vs. Reference Quality Radiations.

Authors:  Thomas J MacVittie; Ann M Farese; William E Jackson
Journal:  Health Phys       Date:  2020-11       Impact factor: 2.922

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.